ANGELA MCCALL-BROWN: Open Payments
NPI 1417259383 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,171 in 87 payments from 14 companies in 2025. Trend: 2023 $128 · 2024 $2,726 · 2025 $4,171
Food & beverage: $2,304Travel & lodging: $1,866
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 13 | $1,948 |
| Abbott Laboratories | 14 | $1,250 |
| Astellas Pharma US Inc | 9 | $190 |
| BridgeBio Pharma, Inc. | 8 | $151 |
| E.R. Squibb & Sons, L.L.C. | 14 | $142 |
| Merck Sharp & Dohme LLC | 7 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| AtriCure, Inc. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
Products named: Barostim Neo System, CARDIOMEMS, Cresemba, Attruby, VERQUVO, CAMZYOS, JARDIANCE, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
